(Q53545796)

15 May 2018

title

Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma. (English)

1 reference

15 May 2018

author name string

Zhong-Xia Wang

1

1 reference

15 May 2018

Chun-Ping Jiang

2

1 reference

15 May 2018

Yin Cao

3

1 reference

15 May 2018

Guang Zhang

4

1 reference

15 May 2018

Wei-Bo Chen

5

1 reference

15 May 2018

Yi-Tao Ding

6

1 reference

15 May 2018

publication date

1 April 2015

1 reference

15 May 2018

Hepatobiliary & Pancreatic Diseases International

published in

1 reference

15 May 2018

volume

14

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

178-185

1 reference

15 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Predictors and patterns of recurrence after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Recurrence of hepatocellular carcinoma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Prognostic benefit of selective portal vein occlusion during hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Surgical treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE: implications for clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Liver enzyme alteration: a guide for clinicians.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Prediction of Portal Vein Invasion by Hepatocellular Carcinoma: A Correlations between Portal Vein Tumor Thrombus and Biochemical Tests

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2815%2960353-8

7 January 2021

10.1016/S1499-3872(15)60353-8

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018